Public health value of universal HPV vaccination

Critical Reviews in Oncology/hematology
Riccardo A AudisioGian Vincenzo Zuccotti

Abstract

The story of Human Papillomavirus vaccination demands reflection not only for its public health impact on the prophylactic management of HPV disease, but also for its relevant economic and social outcomes. Greater than ever data confirm the efficacy and support the urge for effective vaccination plans for both genders before sexual debut. A review of previous experience in gender-restricted vaccination programs has demonstrated a lower effectiveness. Limiting vaccination to women might increase the psychological burden on women by confirming a perceived inequality between genders; and even if all women were immunized, the HPV chain of transmission would still be maintained through men. The cost-effectiveness of including boys into HPV vaccination programs should be re-assessed in view of the progressive drop of the economic burden of HPV-related diseases in men and women due to universal vaccination. The cost of the remarkable increase in anal and oropharyngeal HPV driven cancers in both sexes has been grossly underestimated or ignored. Steps must be taken by relevant bodies to achieve the target of universal vaccination. The analysis of HPV vaccination's clinical effectiveness vs. economic efficacy are supportive of the econom...Continue Reading

References

Mar 3, 2004·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Patricia J EifelDavid G Mutch
May 10, 2006·Nature Clinical Practice. Oncology·Patricia J Eifel
May 11, 2006·Current Medical Research and Opinion·R E BrownS Bénard
Jan 26, 2008·International Journal of Technology Assessment in Health Care·Christine BergeronVanessa Remy
Dec 2, 2008·Gynecologic Oncology·F S MenniniN Largeron
Jul 3, 2009·Journal of the National Cancer Institute·Inge M C M de KokJ Dik F Habbema
Aug 28, 2009·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·Hugo De VuystSilvia Franceschi
Oct 1, 2008·Expert Review of Pharmacoeconomics & Outcomes Research·Erik J DasbachElamin H Elbasha
Jul 14, 2010·European Journal of Public Health·Marko ObradovicMitja Kos
Jul 24, 2010·Gynecologic Oncology·Gabriella FerrandinaGiovanni Scambia
Feb 4, 2011·The New England Journal of Medicine·Anna R GiulianoDalya Guris
Feb 26, 2011·International Journal of Cancer. Journal International Du Cancer·Jacques FerlayDonald Maxwell Parkin
Jul 12, 2011·The Journal of Infectious Diseases·Marc BrissonMarie-Claude Boily
Mar 28, 2012·Journal of Pain & Palliative Care Pharmacotherapy·UNKNOWN Centers for Disease Control and Prevention, Public Health Service, U.S. Department Health
May 12, 2012·The Lancet Oncology·Catherine de MartelMartyn Plummer
Aug 28, 2012·The Lancet Infectious Diseases·Talía MalagónMarc Brisson
Oct 30, 2012·Journal of the National Cancer Institute·Nicolas Van de VeldeMarc Brisson
Nov 28, 2012·PloS One·Gianluca BaioGiampiero Favato
Dec 5, 2012·Vaccine·John T SchillerSuzanne M Garland
Jan 1, 2013·Infectious Agents and Cancer·Beatriz SerranoSilvia de Sanjosé
May 3, 2013·Drug Safety : an International Journal of Medical Toxicology and Drug Experience·Kristine K MacartneyJulia M L Brotherton
Jun 6, 2013·Nature Reviews. Clinical Oncology·Matti Lehtinen, Joakim Dillner
Jul 13, 2013·BMC Public Health·Piergiorgio CrosignaniGian Vincenzo Zuccotti
Jul 25, 2013·Human Vaccines & Immunotherapeutics·Yiling JiangXavier Bresse
Nov 23, 2013·The Journal of Adolescent Health : Official Publication of the Society for Adolescent Medicine·Susan HaririElizabeth R Unger
Mar 19, 2014·BMJ : British Medical Journal·Michael McCarthy
Mar 20, 2014·Pharmacoepidemiology and Drug Safety·Maria-Genalin AngeloFelix Arellano
Jul 22, 2014·APMIS : Acta Pathologica, Microbiologica, Et Immunologica Scandinavica·Elsebeth LyngeMatejka Rebolj
Jul 31, 2014·BMJ : British Medical Journal·Margaret StanleySimon Barton
Jul 31, 2014·BMJ : British Medical Journal·Gillian Prue
Aug 16, 2014·Asian Pacific Journal of Cancer Prevention : APJCP·Takahiro Isshiki

❮ Previous
Next ❯

Citations

Oct 20, 2017·Human Vaccines & Immunotherapeutics·Paolo BonanniUNKNOWN Scientific Board of “Lifetime Immunization Schedule”
Apr 30, 2019·Pathogens and Disease·Hanife Guler DonmezM Sinan Beksac
Sep 28, 2016·World Journal of Gastroenterology : WJG·Dania BucchiGiuseppe Masanotti
Jul 14, 2017·Cost Effectiveness and Resource Allocation : C/E·Francesco Saverio MenniniNathalie Largeron
Jan 15, 2017·International Journal of Gynaecology and Obstetrics : the Official Organ of the International Federation of Gynaecology and Obstetrics·Luciano MarianiAntonio Perino
Sep 3, 2020·International Journal of Environmental Research and Public Health·Jinhee KimSeungJin Bae
Jul 9, 2020·Vaccines·Giovanna Elisa CalabròChiara de Waure
Jun 10, 2017·Health Education Journal·Elaine CarnegieJanette Pow
Jun 13, 2021·The European Journal of Health Economics : HEPAC : Health Economics in Prevention and Care·A MarcellusiG Favato

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.